Back to Search
HOWARD BAILEY, MD
MD
Medical Oncology Physician
NPI: 1861468936Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
29334(WI)
Research & Publications (20)
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer.
PMID 17885756·Cancer Chemother Pharmacol·2008
3-trial
Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid tumors.
PMID 17510207·Clin Cancer Res·2007
3-trial
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma.
PMID 17058289·Cancer·2006
3-trial
A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days.
PMID 15205914·Cancer Chemother Pharmacol·2004
3-trial
A phase II trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern Cooperative Oncology Group Study E2E96.
PMID 12051875·Gynecol Oncol·2002
3-trial
Agenda-based regulation of study-time allocation: when agendas override item-based monitoring.
PMID 19653800·J Exp Psychol Gen·2009
8-other
Number of lymph nodes examined and associated clinicopathologic factors in colorectal carcinoma.
PMID 19415953·Arch Pathol Lab Med·2009
8-other
Non-consultant career grade doctors in genitourinary medicine - are they up to the job? National survey 2007.
PMID 19103886·Int J STD AIDS·2009
8-other
Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies.
PMID 18841362·Cancer Chemother Pharmacol·2009
3-trial
Fetal growth and risk of childhood acute lymphoblastic leukemia: results from an Australian case-control study.
PMID 19478236·Am J Epidemiol·2009
4-observational
Dancing on the Grid: using e-Science tools to extend choreographic research.
PMID 19487213·Philos Trans A Math Phys Eng Sci·2009
8-other
Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study.
PMID 18668698·Hematol Oncol·2009
3-trial
Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
PMID 18786604·Mol Cell Endocrinol·2009
7-preclinical
The design of novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors.
PMID 18775469·Mol Cell Endocrinol·2009
8-other
Does differential strategy use account for age-related deficits in working-memory performance?
PMID 19290740·Psychol Aging·2009
8-other
Persistent leatherback turtle migrations present opportunities for conservation.
PMID 18630987·PLoS Biol·2008
7-preclinical
Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation.
PMID 18523993·Pediatr Blood Cancer·2008
8-other
Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast.
PMID 18227732·Appl Immunohistochem Mol Morphol·2008
8-other
Why does working memory span predict complex cognition? Testing the strategy affordance hypothesis.
PMID 19015498·Mem Cognit·2008
8-other
Violations of behavioral practices revealed in closed claims reviews.
PMID 18791367·Ann Surg·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 HIGHLAND AVE
MADISON, WI 53792 - Phone
- (608) 265-1700
Quick Facts
- NPI
- 1861468936
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile